Cite
HARVARD Citation
Hasselbalch, H. et al. (2021). COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon. Cytokine & growth factor reviews. pp. 28-45. [Online].